Article Sidebar

Published: 2022-04-06
Abstract Views: 1002
DOI: https://doi.org/10.52163/yhc.v63i2.289
Issue
Vol. 63 No. 2 (2022)
Section
Articles
How to Cite
Thái, H. Đức ., Phong, P. V. ., Lâm, Đoàn N. G. ., Trung, V. Q. ., & Thảo, L. T. Q. . (2022). EFFECTIVENESS OF DYSLIPIDEMIA TREATMENT IN TYPE 2 DIABETES PATIENTS. Vietnam Journal of Community Medicine, 63(2). https://doi.org/10.52163/yhc.v63i2.289

EFFECTIVENESS OF DYSLIPIDEMIA TREATMENT IN TYPE 2 DIABETES PATIENTS

Hoang Duc Thai1, Phan Van Phong2, Doan Ngoc Giang Lam3, Vo Quang Trung4, Le Thi Quy Thao4
1 University of Medicine and Pharmacy at Ho Chi Minh city
2 Tay Do University
3 108 Military Central Hospital
4 University of Medicine Pham Ngoc Thach

Main Article Content

Abstract

Objective: To investigate the effectiveness of dyslipidemia treatment in patients with type 2 diabetes at An Phuc General Clinic. Subjects and methods: Prospective cohort study, describing 172 patients diagnosed and treated for type 2 diabetes with primary dyslipidemia at An Phuc General Clinic, from February 2021 to October 2021. Results: The majority of patients were treated with Statins of 67.44%. Then the fibrates group accounted for 24.42%. The resin group was used the least with 12.21%. Most patients treated for dyslipidemia with 1 drug, accounting for 55.81%, mainly statin drugs. The rate of patients experiencing side effects was 36.63%. The percentage of patients who did not reach the goal of treatment for dyslipidemia was still quite high at 37.21%. There was a correlation between reaching the treatment goal and the age group with statistical significance (p<0.05). There was no statistically significant relationship between gender, education level and reaching the treatment goal (p>0.05). There was no statistically significant relationship between achieving the goal of blood lipid treatment and achieving the goal of diabetes treatment (p>0.05). Conclusion: The majority of patients were treated with statins. The rate of patients experiencing side effects and the percentage of patients not reaching the goal of dyslipidemia treatment were still high. There was a relationship between reaching the treatment goal and the age group. There was no relationship between gender, education level and treatment goal achievement. There was no relationship between the achievement of the goal of blood lipid treatment and the achievement of the goal of diabetes treatment.

Article Details

Keywords

Effectiveness of treatment, dyslipidemia, diabetes.

References

1. Saeedi P, Petersohn I, Salpea P, et al., Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition, Diabetes Res Clin Pract, 2019; 157: 107843.
2. Kenneth RF, Carl JEG, Diabetes and dyslipidemia: 2000-2015, 2015.
3. Preiss D, Seshasai SR, Welsh P, et al., Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis, Jama, 2011; 305(24): 2556-64.
4. Bayturan O, Kapadia S, Nicholls SJ, et al., Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol, J Am Coll Cardiol, 2010; 55(24): 2736-42.
5. Kearney PM, Blackwell L, Collins R, et al., Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis, Lancet, 2008; 371(9607): 117-125.
6. Bay VV, Thanh BV, Hung TM, et al., Survey on the use of drugs to treat dyslipidemia in patients with type 2 diabetes at Thong Nhat hospital, HCM City Medical Journal, 2015; 19(5):88-93.
7. Moses SE, Nikos JAN, Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs–the CEPHEUS-Greece survey, Angiology, 2010; 61(5): 465-474.
8. David DW, Carlos B, Cheng WC, et al., Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals, Circulation, 2009;120(1): 28-34.
9. Huong NT, Huyen VTT, Some factors related to lipid metabolism disorders in elderly patients with type 2 diabetes mellitus, Journal of Medical Research, 2015; 94: 72-79.